It's safe to assume at this point that the next generation of Apple Watches might not look dramatically different on the outside, but a fresh rumour suggests one of the wearable’s most controversial ...

An announcement from Masimo ( (MASI)) is now available. On May 1, 2026, Masimo shareholders approved the company’s merger agreement with Danaher Corporation at a virtual special meeting, with roughly ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

A NICU study evaluating Masimo SET® pulse oximetry on hospitalized newborns found no clinically significant differences in ...

Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...

The SET pulse oximetry technology used with a neonate. [Image courtesy of Masimo] Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban.

Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it.